Sort
48,018 grants matching “immunotherapy”
Human Mab Cocktails to Prevent & Treat H5N1 Avian Influenza
$1,444,744Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2010 · AI
Analysis of cancer-related immune suppressor mechanisms in mice
$1,443,413Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
UCLA SPORE in Prostate Cancer
$1,443,180Robert E Reiter · University Of California Los Angeles · P50 · FY2021 · CA
Eliminating Interference from Autofluorescence in Flow Cytometry
$1,441,830Giacomo Vacca · Kinetic River Corporation · R44 · FY2022 · GM
NOVEL COMBINATORIAL TARGETED CHIMERIC ANTIGEN RECEPTOR NATURAL KILLER CELL-BASED CELLULAR IMMUNOTHERAPY WITH ADJUVANT IMMUNOMODULATION IN PATIENTS WITH AML
$1,441,140New York Medical College · · FY2021 · Defense Health Agency
Immunobiology and Immunotherapy of Pediatric Cancer
$1,440,159Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer
$1,440,117Angelo Michael De Marzo · Johns Hopkins University · U54 · FY2024 · CA
NextGen - CRI
$1,440,060Catherine Mary Bollard · Children'S Research Institute · OT2 · FY2025 · CA
COLORADO ADULT AIDS CLINICAL TRIALS UNIT
$1,440,022University Of Colorado Denver · U01 · FY2004 · AI
Admin Core
$1,439,766Carl H. June · University Of Pennsylvania · U54 · FY2019 · CA
Comprehensive SDSU-UCSD Cancer Center Partnership (2 of 2)
$1,438,166Ana M Navarro · University Of California, San Diego · U54 · FY2009 · CA
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,437,689Marina Caskey · Rockefeller University · U01 · FY2024 · AI
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$1,437,333James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · ZID · FY2010 · DK
Preclinical Development of a Thermostable Trivalent Filovirus Vaccine
$1,437,310Axel T Lehrer · University Of Hawaii At Manoa · R01 · FY2017 · AI
ADULT AIDS CLINICAL TRIAL UNIT
$1,436,931University Of Texas Medical Br Galveston · U01 · FY2003 · AI
Heterodimeric IL-15 in Cancer Immunotherapy
$1,436,310George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Immunotherapeutic Approaches for AIDS
$1,436,310George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Cell Prep Core
$1,436,031John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Cell Production Facility Core
$1,436,029Mark Dudley · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Cellular In vivo Imaging
$1,435,868Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The Role of Protein Methylation in Squamous Cell Carcinoma of the Head and Neck
$1,435,614Vassiliki Saloura · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Patient-Based Structural Biology of Tauopathies and TDP-43 Proteinopathies using Cryo-Electron Microscopy and Mass Spectrometry
$1,434,762Anthony William Paul Fitzpatrick · Columbia University Health Sciences · U01 · FY2019 · NS
Targeting exploitable vulnerabilities in T-cell Lymphoma
$1,434,488Samuel Ng · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
T cell recognition of the MR1 presented microbial metabolome
$1,434,057Erin June Adams · University Of Chicago · R01 · FY2019 · AI
GENE EXPRESSION ANALYSIS OF CIRCULATING TUMOR CELLS: A NEXT-GENERATION BIOMARKER TO PREDICT IMMUNOTHERAPY RESPONSE IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA
$1,432,794Vanderbilt University Medical Center · · FY2024 · Defense Health Agency